Portal de Periódicos da CAPES

Diagnosis and therapy of myasthenia gravis—the patients’ perspective: a cross-sectional study

2023; Frontiers Media; Volume: 14; Linguagem: Inglês

10.3389/fneur.2023.1214041

1664-2295

Tomasz Sobierajski, Anetta Lasek‐Bal, Marek Krzystanek, Nils Erik Gilhus,

Antifungal resistance and susceptibility

The survey aimed to explore patients' perspectives with myasthenia gravis (MG) toward the diagnosis made and the therapy used to treat MG. The survey was conducted with a quantitative method, using the CAWI technique. A total of 321 people participated in the survey. More than half of the respondents (56.4%) had suffered from MG for less than 10 years. In three out of 10 cases (30.9%), the diagnosis of MG lasted 3 years or longer. The diagnostic delay was significantly longer in female respondents than in the males (